Identification of alverine and benfluorex as HNF4α activators

ACS Chemical Biology

Volumn 8, Issue 8, 2013, Pages 1730-1736

  Lee, Seung Hee ^a   Athavankar, Sonalee ^a   Cohen, Tom ^a   Piran, Ron ^a   Kiselyuk, Alice ^a   Levine, Fred ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALVERINE; BENFLUOREX; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; INSULIN; MEDIATOR DRUG; PALMITIC ACID; UNCLASSIFIED DRUG;

ARTICLE; BIOCHEMICAL COMPOSITION; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DRUG IDENTIFICATION; DRUG INHIBITION; DRUG MECHANISM; DRUG SAFETY; DRUG SCREENING; DRUG STRUCTURE; GENE EXPRESSION; HIGH THROUGHPUT SCREENING; HYPERLIPIDEMIA; IRRITABLE COLON; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; FENFLURAMINE; GENE EXPRESSION REGULATION; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PROPYLAMINES; PROTEIN BINDING;

EID: 84882773538     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb4000986     Document Type: Article

References (51)

1. Porte, D., Jr. and Kahn, S. E. (2001) Beta-cell dysfunction and failure in type 2 diabetes: Potential mechanisms Diabetes 50 (Suppl 1) S160-163
2. Poitout, V. (2008) Glucolipotoxicity of the pancreatic beta-cell: Myth or reality? Biochem. Soc. Trans. 36, 901-904
3. Unger, R. H. (1995) Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications Diabetes 44, 863-870
4. Maedler, K., Spinas, G. A., Dyntar, D., Moritz, W., Kaiser, N., and Donath, M. Y. (2001) Distinct effects of saturated and monounsaturated fatty acids on beta-cell turnover and function Diabetes 50, 69-76
5. Hagman, D. K., Hays, L. B., Parazzoli, S. D., and Poitout, V. (2005) Palmitate inhibits insulin gene expression by altering PDX-1 nuclear localization and reducing MafA expression in isolated rat islets of Langerhans J. Biol. Chem. 280, 32413-32418
6. Kelpe, C. L., Moore, P. C., Parazzoli, S. D., Wicksteed, B., Rhodes, C. J., and Poitout, V. (2003) Palmitate inhibition of insulin gene expression is mediated at the transcriptional level via ceramide synthesis J. Biol. Chem. 278, 30015-30021
7. Jacqueminet, S., Briaud, I., Rouault, C., Reach, G., and Poitout, V. (2000) Inhibition of insulin gene expression by long-term exposure of pancreatic beta cells to palmitate is dependent on the presence of a stimulatory glucose concentration Metabolism 49, 532-536
8. Kiselyuk, A., Lee, S. H., Farber-Katz, S., Zhang, M., Athavankar, S., Cohen, T., Pinkerton, A. B., Ye, M., Bushway, P., Richardson, A. D., Hostetler, H. A., Rodriguez-Lee, M., Huang, L., Spangler, B., Smith, L., Higginbotham, J., Cashman, J., Freeze, H., Itkin-Ansari, P., Dawson, M. I., Schroeder, F., Cang, Y., Mercola, M., and Levine, F. (2012) HNF4α antagonists discovered by a high-throughput screen for modulators of the human insulin promoter Chem. Biol. 19, 806-818
9. Cohen, T., Sundaresh, S., and Levine, F. (2012) Antipsychotics activate the TGFβ pathway effector SMAD3 Mol. Psychiatry 18, 347-357
10. Kiselyuk, A., Farber-Katz, S., Cohen, T., Lee, S. H., Geron, I., Azimi, B., Heynen-Genel, S., Singer, O., Price, J., Mercola, M., Itkin-Ansari, P., and Levine, F. (2010) Phenothiazine neuroleptics signal to the human insulin promoter as revealed by a novel high-throughput screen J. Biomol. Screen. 15, 663-670
11. Eeckhoute, J., Briche, I., Kurowska, M., Formstecher, P., and Laine, B. (2006) Hepatocyte nuclear factor 4α ligand binding and F domains mediate interaction and transcriptional synergy with the pancreatic islet LIM HD transcription factor Isl1 J. Mol. Biol. 364, 567-581
12. Bartoov-Shifman, R., Hertz, R., Wang, H., Wollheim, C. B., Bar-Tana, J., and Walker, M. D. (2002) Activation of the insulin gene promoter through a direct effect of hepatocyte nuclear factor 4α J. Biol. Chem. 277, 25914-25919
13. Gupta, R. K., Vatamaniuk, M. Z., Lee, C. S., Flaschen, R. C., Fulmer, J. T., Matschinsky, F. M., Duncan, S. A., and Kaestner, K. H. (2005) The MODY1 gene HNF4α regulates selected genes involved in insulin secretion J. Clin. Invest. 115, 1006-1015
14. Stoffel, M. and Duncan, S. A. (1997) The maturity-onset diabetes of the young (MODY1) transcription factor HNF4α regulates expression of genes required for glucose transport and metabolism Proc. Natl. Acad. Sci. U.S.A. 94, 13209-13214
15. Yamagata, K., Furuta, H., Oda, N., Kaisaki, P. J., Menzel, S., Cox, N. J., Fajans, S. S., Signorini, S., Stoffel, M., and Bell, G. I. (1996) Mutations in the hepatocyte nuclear factor 4α gene in maturity-onset diabetes of the young (MODY1) Nature 384, 458-460
16. Moulin, P., Andre, M., Alawi, H., Dos Santos, L. C., Khalid, A. K., Koev, D., Moore, R., Serban, V., Picandet, B., and Francillard, M. (2009) Efficacy of benfluorex in combination with sulfonylurea in type 2 diabetic patients: An 18 to 34-week, open-label, extension period Diabetes Metab. 35, 64-70
17. Wittmann, T., Paradowski, L., Ducrotte, P., Bueno, L., and Andro Delestrain, M. C. (2010) Clinical trial: The efficacy of alverine citrate/simeticone combination on abdominal pain/discomfort in irritable bowel syndrome-A randomized, double-blind, placebo-controlled study Aliment Pharmacol. Ther. 31, 615-624
18. Buth, W., Kulz, F., and Rosemund, K. W. (1939) Über Synthesen spasmolytisch wirkendender Stoffe Ber. Dtsch. Chem. Ges. B 72, 19-28
19. Kulz, F., Rosenmund, K. W., Kayser, E., Schwarzhaupt, O., and Sommer, H. (1939) Über Synthesen spasmolytisch wirkender Stoffe. II. Mitteilung Ber. Dtsch. Chem. Ges. 72, 2161-2167
20. Mitchell, S. A., Mee, A. S., Smith, G. D., Palmer, K. R., and Chapman, R. W. (2002) Alverine citrate fails to relieve the symptoms of irritable bowel syndrome: Results of a double-blind, randomized, placebo-controlled trial Aliment Pharmacol. Ther. 16, 1187-1195
21. Hayase, M., Hashitani, H., Suzuki, H., Kohri, K., and Brading, A. F. (2007) Evolving mechanisms of action of alverine citrate on phasic smooth muscles Br. J. Pharmacol. 152, 1228-1238
22. Coelho, A. M., Jacob, L., Fioramonti, J., and Bueno, L. (2001) Rectal antinociceptive properties of alverine citrate are linked to antagonism at the 5-HT1A receptor subtype J. Pharm. Pharmacol. 53, 1419-1426
23. Beregi, L., Pierre, H., and Le Douarec, J. C. (1969) Trifluoromethyl Derivatives of Phenyl Amino Propanes as Anorexiants, Analgesics, Anticonvulsants, or Lipid Metabolism Regulators, Science Union et Cie., Societe Francaise de Recherche Medicale, France.
24. Brindley, D. N. (1993) Mechanisms for the effects of benfluorex on the obese-diabetic-dyslipidemic syndrome Diabetes/Metab. Rev. 9 (Suppl 1) 51S-56S
25. Moulin, P., Andre, M., Alawi, H., dos Santos, L. C., Khalid, A. K., Koev, D., Moore, R., Serban, V., Picandet, B., and Francillard, M. (2006) Efficacy of benfluorex in combination with sulfonylurea in type 2 diabetic patients: An 18-week, randomized, double-blind study Diabetes Care 29, 515-520
26. Porter, R. H., Benwell, K. R., Lamb, H., Malcolm, C. S., Allen, N. H., Revell, D. F., Adams, D. R., and Sheardown, M. J. (1999) Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B, and 5-HT2C receptors in CHO-K1 cells Br. J. Pharmacol. 128, 13-20
27. Boutet, K., Frachon, I., Jobic, Y., Gut-Gobert, C., Leroyer, C., Carlhant-Kowalski, D., Sitbon, O., Simonneau, G., and Humbert, M. (2009) Fenfluramine-like cardiovascular side-effects of benfluorex Eur. Respir. J. 33, 684-688
28. Connolly, H. M., Crary, J. L., McGoon, M. D., Hensrud, D. D., Edwards, B. S., Edwards, W. D., and Schaff, H. V. (1997) Valvular heart disease associated with fenfluramine-phentermine N. Engl. J. Med. 337, 581-588
29. Noize, P., Sauer, M., Bruneval, P., Moreau, M., Pathak, A., Bagheri, H., and Montastruc, J. L. (2006) Valvular heart disease in a patient taking benfluorex Fundam. Clin. Pharmacol. 20, 577-578
30. Fournier, A. and Zureik, M. (2012) Estimate of deaths due to valvular insufficiency attributable to the use of benfluorex in France Pharmacoepidemiol. Drug Saf. 21, 343-351
31. Prescrire (2011) Lessons from the Mediator scandal Prescrire Int. 20, 284
32. Kmietowicz, Z. (2011) European drug regulator is being investigated by fraud agency BMJ 343, d7283
33. Ravel, D. and Laudignon, N. (1996) Research prospects with benfluorex J. Diabetes Complications 10, 246-254
34. Kohl, C., Ravel, D., Girard, J., and Pegorier, J. P. (2002) Effects of benfluorex on fatty acid and glucose metabolism in isolated rat hepatocytes: From metabolic fluxes to gene expression Diabetes 51, 2363-2368
35. Mayr, L. M. and Bojanic, D. (2009) Novel trends in high-throughput screening Curr. Opin. Pharmacol. 9, 580-588
36. Dhe-Paganon, S., Duda, K., Iwamoto, M., Chi, Y. I., and Shoelson, S. E. (2002) Crystal structure of the HNF4α ligand binding domain in complex with endogenous fatty acid ligand J. Biol. Chem. 277, 37973-37976
37. Yuan, X., Ta, T. C., Lin, M., Evans, J. R., Dong, Y., Bolotin, E., Sherman, M. A., Forman, B. M., and Sladek, F. M. (2009) Identification of an endogenous ligand bound to a native orphan nuclear receptor PLoS One 4, e5609
38. Bailly, A., Torres-Padilla, M. E., Tinel, A. P., and Weiss, M. C. (2001) An enhancer element 6 kb upstream of the mouse HNF4α1 promoter is activated by glucocorticoids and liver-enriched transcription factors Nucleic Acids Res. 29, 3495-3505
39. Lomenick, B., Hao, R., Jonai, N., Chin, R. M., Aghajan, M., Warburton, S., Wang, J., Wu, R. P., Gomez, F., Loo, J. A., Wohlschlegel, J. A., Vondriska, T. M., Pelletier, J., Herschman, H. R., Clardy, J., Clarke, C. F., and Huang, J. (2009) Target identification using drug affinity responsive target stability (DARTS) Proc. Natl. Acad. Sci. U.S.A. 106, 21984-21989
40. Stanger, B. Z. (2008) HNF4α and diabetes: Injury before insult? Diabetes 57, 1461-1462
41. Wang, H., Maechler, P., Antinozzi, P. A., Hagenfeldt, K. A., and Wollheim, C. B. (2000) Hepatocyte nuclear factor-4α regulates the expression of pancreatic beta-cell genes implicated in glucose metabolism and nutrient-induced insulin secretion J. Biol. Chem. 275, 35953-35959
42. Odom, D. T., Zizlsperger, N., Gordon, D. B., Bell, G. W., Rinaldi, N. J., Murray, H. L., Volkert, T. L., Schreiber, J., Rolfe, P. A., Gifford, D. K., Fraenkel, E., Bell, G. I., and Young, R. A. (2004) Control of pancreas and liver gene expression by HNF transcription factors Science 303, 1378-1381
43. Hayhurst, G. P., Lee, Y. H., Lambert, G., Ward, J. M., and Gonzalez, F. J. (2001) Hepatocyte nuclear factor 4α (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis Mol. Cell. Biol. 21, 1393-1403
44. NRIM Limited. ((2009) Public Assessment Report, Decentralized Procedure, Alverine Citrate 60 mg and 120 mg Capsules, U.K. Licence No: PL20620/0037-8, Medicines and Healthcare Products Regulatory Agency, United Kingdom.
45. van Sommeren, S., Visschedijk, M. C., Festen, E. A., de Jong, D. J., Ponsioen, C. Y., Wijmenga, C., and Weersma, R. K. (2011) HNF4α and CDH1 are associated with ulcerative colitis in a Dutch cohort Inflamm. Bowel Dis. 17, 1714-1718
46. Ahn, S. H., Shah, Y. M., Inoue, J., Morimura, K., Kim, I., Yim, S., Lambert, G., Kurotani, R., Nagashima, K., Gonzalez, F. J., and Inoue, Y. (2008) Hepatocyte nuclear factor 4α in the intestinal epithelial cells protects against inflammatory bowel disease Inflamm. Bowel Dis. 14, 908-920
47. Liebregts, T., Adam, B., Bredack, C., Roth, A., Heinzel, S., Lester, S., Downie-Doyle, S., Smith, E., Drew, P., Talley, N. J., and Holtmann, G. (2007) Immune activation in patients with irritable bowel syndrome Gastroenterology 132, 913-920
48. Akiho, H., Ihara, E., and Nakamura, K. (2010) Low-grade inflammation plays a pivotal role in gastrointestinal dysfunction in irritable bowel syndrome World J. Gastrointest. Pathophysiol. 1, 97-105
49. Halpin, S. J. and Ford, A. C. (2012) Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: Systematic review and meta-analysis Am. J. Gastroenterol. 107, 1474-1482
50. Ball, A. J., Abrahamsson, A. E., Tyrberg, B., Itkin-Ansari, P., and Levine, F. (2007) HES6 reverses nuclear reprogramming of insulin-producing cells following cell fusion Biochem. Biophys. Res. Commun. 355, 331-337
51. Quirk, S. J., Gannell, J. E., Fullerton, M. J., and Funder, J. W. (1986) Mechanisms of biphasic action of glucocorticoids on α-lactalbumin production by rat mammary gland explants J. Steroid Biochem. 24, 413-416